A low-dose antibiotic developed in Leiden might cease C. difficile infections extra successfully by concentrating on the pathogen whereas preserving the intestine microbiome. Researchers in Leiden have developed a brand new antibiotic referred to as EVG7 that may fight the harmful intestine bacterium C. difficile utilizing solely a really small dose. The therapy additionally sharply reduces the possibilities that […]
Source link











